Mymetics Corp (MYMX)

[bow-tie]

CONCLUSION — Vaccination against seasonal influenza is recommended for all persons ≥6 months old, including pregnant women. Quadrivalent vaccines offer broader coverage against influenza B viruses, which primarily infect children. The intranasal live-attenuated vaccine is once again an ACIP-recommended option for the 2018-19 season. Recombinant, high-dose, and adjuvanted vaccines elicit greater antibody responses than standard-dose unadjuvanted vaccines in persons ≥65 years old, and the high-dose and recombinant vaccines have been shown in randomized controlled trials to be more effective in older patients in preventing laboratory-confirmed influenza.